Elisabeth Carilla-Durand

Author

Pierre Fabre (France)

Also Known As

E Carilla-Durand, E. Carilla-Durand, Elisabeth Carilla-Durand

Publications

535

Citations

H-Index

Concepts

All Affiliations

Pierre Fabre (France)

About

Elisabeth Carilla-Durand is an author at Pierre Fabre (France) specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	415
2	Health Sciences	1	1	136
3	Natural Sciences	1	1	31
4	Social Sciences	1	1	106
5	Biochemistry	1	1	31

Elisabeth Carilla-Durand

Publications

516

Citations

H-Index

Page 1

	Year	Citations
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia Françis C. Colpaert, J.P. Tarayre, Wouter Koek, Neuropharmacology Molecular PharmacologyPain SyndromeHealth SciencesAcute PainPain Medicine	2002	136
F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair, The International Journal of Neuropsychopharmacology In-vivo ProfileNeurotransmitterPsychopharmacologyExperimental PharmacologySocial Sciences	2010	106
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release Cristina Cosi, Elisabeth Carilla-Durand, M.B. Assié, European Journal of Pharmacology PsychiatryFunctional SelectivityMedicinePsychopharmacologySchizophrenia	2006	88
F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential Wouter Koek, Jean‐François Patoiseau, M.B. Assié, Journal of Pharmacology and Experimental Therapeutics	1998	63
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063 Marie‐Bernadette Assié, Elisabeth Carilla-Durand, Laurent Bardin, European Journal of Pharmacology Psychoactive DrugPsychiatryMedicineOlanzapine Increase PlasmaPsychotropic Medication	2008	54
F 11356, a Novel 5-Hydroxytryptamine (5-HT) Derivative with Potent, Selective, and Unique High Intrinsic Activity at 5-HT1B/1D Receptors in Models Relevant to Migraine Gareth W. John, Petrus J. Pauwels, Michel Perez, Journal of Pharmacology and Experimental Therapeutics	1999	38
Pharmacological profile of F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor Didier Junquéro, Philippe Oms, Elisabeth Carilla-Durand, Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceSystemic AcylcoenzymeOxysterol	2001	31

Page 1